FDA Can’t Inspect Its Way Out Of Import Safety Problems – Schultz, Sharfstein
This article was originally published in The Gray Sheet
Executive Summary
Increasing the number of foreign device facility inspections alone will not dramatically improve FDA import safety, agency leaders say
You may also be interested in...
Draft Guidance: Clean ISO Audit Report May Permit Delayed FDA Inspections
Device companies may be able to put off an FDA facility inspection if the plant has recently satisfied international quality system standards, according to a 1draft guidance released by the agency May 20
Draft Guidance: Clean ISO Audit Report May Permit Delayed FDA Inspections
Device companies may be able to put off an FDA facility inspection if the plant has recently satisfied international quality system standards, according to a 1draft guidance released by the agency May 20
Q&A: Former CDRH Director Dan Schultz On Communication Issues, 510(k)s
For former FDA device center director Dan Schultz, his new job since leaving the agency may feel a bit familiar: explaining FDA's sometimes convoluted processes to frustrated device firms